A novel N

Area of Science:

• Epigenetics and molecular biology
• Immunology and host-pathogen interactions
• Genetics and genomics

Background:

• N6-Methyldeoxyadenine (6mA) is a DNA modification with emerging biological significance in metazoans.
• The precise roles and regulatory mechanisms of 6mA in eukaryotes remain largely unknown.
• Understanding 6mA's function is crucial for comprehending epigenetic regulation in complex organisms.

Purpose of the Study:

• To investigate the dynamic changes in genomic 6mA levels during pathogenic infection in Caenorhabditis elegans (C. elegans).
• To identify the specific enzyme responsible for catalyzing 6mA modifications in response to infection.
• To elucidate the functional role of 6mA and its associated enzymes in the innate immune response.

Main Methods:

• Quantitative analysis of genomic 6mA levels in C. elegans under pathogen challenge.
• Identification and characterization of the methyltransferase enzyme involved in 6mA formation.
• Gene expression analysis to assess the impact on innate immune response genes.
• Phenotypic analysis of animal susceptibility to infection in the absence of the identified methyltransferase.

Main Results:

• Genomic 6mA levels were found to fluctuate significantly upon exposure to pathogens in C. elegans.
• METL-9 was identified as the key methyltransferase responsible for catalyzing DNA 6mA modifications during infection.
• METL-9 deficiency led to impaired induction of innate immune genes and increased susceptibility to infection.
• METL-9 was shown to regulate innate immunity through both 6mA-dependent and 6mA-independent pathways.

Conclusions:

• 6mA is a functional epigenetic modification involved in the immunomodulation of C. elegans.
• METL-9 plays a critical role in the host defense response to pathogens via epigenetic regulation.
• The study highlights the intricate interplay between DNA modifications and innate immunity, opening new avenues for research.